» Development of Strategic Business Plans
» Due Diligence and Business Development
» Primary Market Research
» Advisory Boards
» Sales, Market, and Manufacturing Capacity Forecasting

Due Diligence and Business Development

DCi Biotech is experienced with business development and conducting due diligence in the medical industry. Our expertise is in biotechnology licensing, mergers and acquisitions. We can help you identify and pursue emerging opportunities through in- or out-licensing, and connect with suitable partners.

We can also:

  • Conduct due diligence for licensing, investment or acquisitions
  • Identify key regenerative medicine targets and companies
  • Assess and rank opportunities
  • Assist with presentations and initial negotiations

Case Study

A global pharmaceutical company wanted to invest in early stage cell therapies for the treatment of diabetes. DCi was contracted to identify, assess, and recommend potential therapies for in-licensing and companies for acquisition within the EMEA-region. DCi recommended several clinical-stage technologies, including therapeutics and diagnostics.

DCi was later contracted by the company to conduct primary market research with diabetes experts to assess the individual therapies.